Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.125 USD | +0.45% | +4.09% | +32.37% |
May. 08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
May. 08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.37% | 132M | |
+4.01% | 111B | |
+11.45% | 105B | |
-12.60% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.43% | 16.96B | |
+3.07% | 13.7B | |
+37.03% | 12.45B |
- Stock Market
- Equities
- KPTI Stock
- News Karyopharm Therapeutics Inc.
- HC Wainwright Adjusts Karyopharm Therapeutics' Price Target to $22 from $23, Keeps Buy Rating